Toward improved statistical methods for analyzing Cotinine-Biomarker health association data.
Tulay Koru-Sengul1,2, John D Clark1,3, Lora E Fleming1,4
1Department of Epidemiology and Public Health at Leonard Miller School of Medicine, University of Miami, Miami, Florida, USA.
Tobacco Induced Diseases
|October 5, 2011
Summary
Analyzing serum cotinine data with values below the limit of detection (LOD) requires careful statistical methods. The "reverse" Kaplan-Meier approach may offer the most accurate results for secondhand smoke (SHS) biomarker analysis.
Area of Science:
- Environmental Health
- Biomarkers
- Statistical Analysis
Background:
- Serum cotinine is a key biomarker for recent tobacco smoke exposure.
- Traditional secondhand smoke (SHS) research faces challenges with censored data below the limit of detection (LOD).
Purpose of the Study:
- To compare statistical methods for analyzing censored serum cotinine data.
- To evaluate the impact of different methods on the association between cotinine and homocysteine.
Main Methods:
- Utilized data from the 1999-2004 National Health and Nutrition Examination Surveys (NHANES).
- Compared complete case analysis, imputation techniques (single and multiple), "reverse" Kaplan-Meier, and logistic regression.
- Examined associations between serum cotinine and the inflammatory marker homocysteine.
Main Results:
- Statistical significance and parameter estimates varied significantly based on the method used for censored cotinine values.
- Multiple imputation resulted in smaller, non-significant estimates compared to other methods.
- "Reverse" Kaplan-Meier yielded statistically significant and larger estimates than parametric methods.
Conclusions:
- Analysis of serum cotinine data with values below LOD necessitates specialized statistical approaches.
- "Reverse" Kaplan-Meier uniquely handles censored data with multiple LODs, potentially offering superior accuracy by avoiding data manipulation.
- Further research is essential to establish optimal statistical methods for SHS biomarkers with LOD constraints.
Related Concept Videos
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:28Criteria for Causality: Bradford Hill Criteria - II
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...